HIV-1 coat protein gp120 decreases NO-dependent cyclic GMP accumulation in rat brain astroglia by increasing cyclic GMP phosphodiesterase activity

Neurochemistry International

Volumn 45, Issue 6, 2004, Pages 937-946

  Navarra, Michele ^a   Antonia Baltrons, María ^a   Sardón, Teresa ^a   Pedraza, Carlos E ^a   García, Agustina ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

cGMP; gp120; Phosphodiesterase 5

Indexed keywords

BRAIN ENZYME; CALCIUM; CELL EXTRACT; COAT PROTEIN; CYCLIC GMP; CYCLIC GMP PHOSPHODIESTERASE; GLYCOPROTEIN GP 120; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V; ROLIPRAM; SILDENAFIL; VIRUS PROTEIN; ZAPRINAST;

ANIMAL CELL; ANIMAL MODEL; ASTROCYTE; BRAIN NERVE CELL; CELL FUNCTION; CELL PROLIFERATION; CEREBELLUM; CONFERENCE PAPER; CONTROLLED STUDY; DEMENTIA; ENZYME ACTIVITY; GLIA CELL; HIV ASSOCIATED DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROGLIA; MICROGLIA; NERVE CELL CULTURE; NEUROPATHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT; SIGNAL TRANSDUCTION;

1-METHYL-3-ISOBUTYLXANTHINE; 3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; ASTROCYTES; BRAIN CHEMISTRY; CELLS, CULTURED; CYCLIC AMP; FLOW CYTOMETRY; FLUORESCENT DYES; GUANYLATE CYCLASE; HIV ENVELOPE PROTEIN GP120; MICROGLIA; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PURINONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RODENTIA;

EID: 4243185767     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.03.024     Document Type: Conference Paper

References (64)

1. Agulló L., García A. Different receptors mediate stimulation of nitric oxide-dependent cyclic GMP formation in neurons and astrocytes in culture. Biochem. Biophys. Res. Commun. 182:1992;1362-1368
2. Agulló L., Baltrons M.A., García A. Calcium-dependent nitric oxide formation in glial cells. Brain Res. 686:1995;160-168
3. 2+/calmodulin dependent cyclic GMP phosphodiesterase activity in granule neurons and astrocytes from cerebellum. Eur. J. Pharmacol. 323:1997;119-125
4. Andreeva S.G., Dikkes P., Epstein P.M., Rosenberg P.A. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J. Neurosci. 21:2001;9068-9076
5. Araque A., Carmignoto G., Haydon P.G. Dynamic signaling between astrocytes and neurons. Annu. Rev. Physiol. 63:2001;795-813
6. Bagasra O., Lavi E., Lobroski L., Khalili K., Pestaner J.B., Pomerantz R.J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ PCR and immunochemistry. AIDS. 10:1996;573-585
7. Bagetta G., Corasaniti M.T., Berliocchi L., Nisticó G., Giammarioli A.M., Malorni W., Aloe L., Finazzi-Agró A. Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1(HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience. 89:1999;1051-1066
8. Baltrons M.A., Saadoun S., Agulló L., García A. Regulation by calcium of the nitric oxide/cyclic GMP system in cerebellar granule cells and astroglia in culture. J. Neurosci. Res. 49:1997;333-341
9. Baltrons M.A., García A. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells. J. Neurochem. 73:1999;2149-2157
10. Baltrons M.A., Pedraza C.E., Heneka M.T., García A. β-Amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells. Neurobiol. Dis. 10:2002;139-149
11. Bellamy T.C., Garthwaite J. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. Mol. Pharmacol. 59:2001;54-61
12. Benos, D.J., Hahn, B.H., Bubien, J.K., Ghosh, S.K., Mashburn, N.A., Chaikin, M.A., Shaw, G.M., Benveniste, E.N., 1994. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex. Proc. Natl. Acad. Sci. U.S.A. 91, 494-498.
13. Bezzi P., Domercq M., Brambilla R., Galli R., Schols D., De Clerq E., Vescovi A., Bagetta G., Kpllias G., Meldolesi J., Volterra A. CXCR4-activated astrocyte glutamate release via TNF-α: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4:2001;702-710
14. Boven L.A., Gomes L., Hery C., Gray F., Verhoef J., Portegies P., Tardieu M., Nottet H.S.L.M. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J. Immunol. 162:1999;4319-4327
15. Brenneman D.E., McCune S.K., Mervis R.F., Hill J.M. gp120 as an etiologic agent for neuroAIDS: neurotoxicity and model systems. Adv. Neuroimmunol. 4:1994;157-165
16. Brooker G., Harper J.F., Terasaki W.L., Moylan R.D. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10:1979;1-33
17. Bukrinsky M.I., Nottet H., Shmidtmayerova H., Dubrovsky L., Flanagan C.R., Mullins M.E., Lipton S.A., Gendelman H.E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type-1 (HIV-1) infected monocytes: implication for HIV-associated neurological disease. J. Exp. Med. 181:1995;735-745
18. i increases in a glial cell subpopulation. Eur. J. Neurosci. 5:1993;1711-1718
19. Corbin D.J., Turko I.V., Beasley A., Sharron H.F. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. Eur. J. Biochem. 267:2000;2760-2767
20. De Vente, J., Steinbusch, H.W.M., 2000. Nitric oxide-cGMP signaling in the rat brain. In: Steinbusch, H.W.M., De Vente, J., Vincent, S.R. (Eds.), Handbook of Chemical Anatomy, Vol. 17: Functional Neuroanatomy of the Nitric Oxide System, Elsevier, pp. 355-415.
21. Dreyer E.B., Lipton S.A. The coat protein gp120 of HIV-1 inhibits astrocyte uptake of excitatory amino acids via macrophage arachidonic acid. Eur. J. Neurosci. 7:1995;2502-2507
22. Fisher D.A., Smith J.F., Pillar J.S., St Denis S.H., Cheng J.B. Isolation and characterization of PDE 9A, a novel human cGMP-specific phosphodiesterase. J. Biol. Chem. 273:1998;15559-155564
23. Furuyama T., Iwahashi-Tano Y., Takagi H., Inagaki S. Localization of 63-kDa calmodulin-stimulated phosphodiesterase mRNA in the rat brain by in situ hybridization histochemistry. Mol. Brain Res. 26:1994;331-336
24. Garthwaite J., Boulton C.L. Nitric oxide signalling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-706
25. Gelman B.B. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann. Neurol. 34:1993;65-70
26. Genis P., Jett M., Berton E.W., Boyle T., Gelbard H.A., Dzenko K., Keane R.V., Resnick L., Mizrachi Y., Volsky D.J., Epstein L.G., Gendelman H.E. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV-1)-infected macrophage-astroglia interaction: implications for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1992;1703-1718
27. 15N] nitrate in biological fluids. Ann. Biochem. 126:1982;131-138
28. Kaul M., Garden C.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 410:2001;988-994
29. Kiemer A.K., Weber N.C., Vollmar A.M. Induction of IkB: atrial natriuretic peptide as a regulator of the NF-kB pathway. Biochem. Biophys. Res. Commun. 295:2002;1068-1076
30. Kim Y.M., Chung H.T., Kim S.S., Han J.A., Yoo Y.M., Kim K.M., Lee G.H., Yun H.Y., Green A., Li J., Simmons R.L., Billiar T.R. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signalling. J. Neurosci. 19:1999;6740-6747
31. Koenig S., Gendelman H.E., Orenstein J.M., Dal Canto M.C., Pozeshkpour G.H., Yungbluth M., Janotta F., Aksamit A., Martin A., Fauci A.S. Detection of AIDS virus in macrophages in brain tissue from AIDS patient with encephalopathy. Science. 233:1986;1089-1093
32. Koka P., He K., Zack J.A., Kitchen S., Peacock W., Fried I., Tran T., Yashar S.S., Merril J.E. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor-α and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J. Exp. Med. 182:1995;941-951
33. Kong L.Y., Wilson B.C., McMillian M.K., Bing G., Hudson P.M., Hong G.S. The effects of HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol. 172:1996;77-83
34. Kotera J., Yanaka N., Fujishige K., Imai Y., Akatsuka H., Ishizuka T., Kawashima K., Omori K. Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development. Eur. J. Biochem. 249:1997;434-442
35. Kotera J., Kotomi F., Omori K. Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues. J. Histochem. Cytochem. 48:2000;685-693
36. Levi, G., Patrizio, M., Bernardo, A., Petrucci, T.C., Agresti, C., 1995. Human immunodeficiency virus coat protein gp120 inhibits the β-adrenergic regulation of astroglial and microgila functions. Proc. Natl. Acad. Sci. U.S.A. 90, 1541-1545.
37. Lipton S.A., Gendelman H.E. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:1995;934-940
38. Lowry O.M., Roebrough N.J., Farr A.L., Randall R.J. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275
39. 2+. J. Neurochem. 59:1992;2024-2029
40. Merrill J.E., Chen I.S.Y. HIV-1, macrophages, glial cells and citokines in AIDS nervous system disease. FASEB J. 25:1991;2391-2397
41. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125
42. Mollace V., Colasanti M., Persichini T., Bagetta G., Lauro G.M., Nisticò G. HIV-1 gp120 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem. Biophys. Res. Commun. 194:1993;439-445
43. Mullershausen F., Friebe A., Feil R., Thompson W.J., Hofmann F., Koesling D. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signalling. J. Cell Biol. 160:2003;719-727
44. Murphy S. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia. 29:2000;1-14
45. Nath A., Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog. Neurobiol. 54:1998;19-33
46. Navarra, M., Pedraza, C.E., Sardón, T., Baltrons, M.A., García, A., 2002. HIV-1 coat protein GP120 decreases NO-dependent cGMP accumulation in rat brain astrocytes by increasing phosphodiesterase 5 activity. Glia S1, S28.
47. Okada D., Asakawa S. Allosteric activation of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) by cGMP. Biochemistry. 41:2002;9672-9679
48. Pedraza C.E., Baltrons M.A., Heneka M.T., García A. Interleukin-1β and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNA. J. Neuroimmunol. 144:2003;80-90
49. Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., Cleary P. The brain and AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science. 239:1988;586-592
50. Rybalkin S.D., Rybalkina I.G., Shimizu-Albergine M., Tang X.B., Beavo J.A. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain. EMBO J. 22:2003;469-478
51. Sharma R.K., Adachi A., Adachi K., Wang J.H. Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies. J. Biol. Chem. 259:1984;9248-9254
52. Soderling S.H., Beavo J.A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell Biol. 12:2000;174-179
53. Takuma K., Phuagphong P., Lee E., Mori K., Baba A., Matsuda T. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J. Biol. Chem. 276:2001a;48093-48099
54. Takuma K., Lee E., Enomoto R., Mori K., Baba A., Matsuda T. Ibudilast attenuates astrocyte apoptosis via cyclic GMP signalling pathway in an in vitro reperfusion model. Br. J. Pharmacol. 133:2001b;841-848
55. Turko I.V., Francis S.H., Corbin J.D. Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation. Biochem. J. 329:1998;505-510
56. Toggas S.M., Mashllah E., Rockenstein E.M., Rall G.F., Abraham C.R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193
57. Vesce S., Bezzi P., Rossi D., Meldolesi J., Volterra A. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting uptake and stimulating the release of the aminoacid. FEBS Lett. 411:1997;107-109
58. van Staveren W.C.G., Markerink-van Ittersum M., Steinbusch H.W.M., de Vente J. The effects of phosphodiesterase inhibition on cyclic GMP and cyclic AMP accumulation in the hippocampus of the rat. Brain Res. 888:2001;275-286
59. Weis S., Haug H., Budka H. Astroglial changes in cerebral cortex of AIDS brains: a morphometric and immunohistochemical investigation. Neuropathol. Appl. Neurobiol. 19:1993;329-335
60. 2+ waves in glia. J. Neurosci. 20:2000;1767-1779
61. Wiss-Coray T., Masliah E., Toggas S.M., Rockenstein E.M., Brooker M.J., Lee H.S., Mucke L. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97:1996;789-798
62. Xiong H., Yamada K., Jourdi H., Kawamura M., Takei N., Han D., Nabeshima T., Nawa H. Regulation of nerve growth factor release by nitric oxide through cyclic GMP pathway in cortical glial cells. Mol. Pharmacol. 56:1999;339-347
63. Yan C., Bentley J.K., Sonnenburg W.K., Beavo J.A. Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain. J. Neurosci. 14:1994;973-984
64. Zhang J., Snyder S.H. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35:1995;213-233